Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03605303 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process
A NA study, sponsored by Johnson & Johnson Vision Care.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03605303 is a NA study that was terminated before completion, run by Johnson & Johnson Vision Care. The registered enrollment target is 3 participants.
The verdict
NCT03605303, a NA study, was terminated before completion, sponsored by Johnson & Johnson Vision Care.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is a multi-site, group sequential, adaptive, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.
Interventions
- DEVICE Test/Control
- DEVICE Control/Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-07-03 |
| Est. Completion | 2018-07-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03605303
The ClinicalTrials.gov registry entry for NCT03605303 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Test/Control is the first listed.
NCT03605303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03605303 about?
NCT03605303 is a clinical study titled "Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process". This study is a multi-site, group sequential, adaptive, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear bilaterally both Test and Control lenses in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the ...
What is the current status of trial NCT03605303?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2018-07-03. Estimated completion is 2018-07-05.
What interventions are being tested in trial NCT03605303?
The interventions under investigation include: Test/Control (DEVICE), Control/Test (DEVICE).
Who is sponsoring clinical trial NCT03605303?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.